

Paediatric obesity care is entering a period of rapid clinical transformation, driven by the arrival of next generation obesity management medications (OMMs). This shift creates new opportunities for effective treatment but also potentially introduces new risks if nutritional care is not carefully considered and monitored alongside the prescription of these medications.
Diabetes & Endocrinology
|11th Mar, 2026
|The Lancet
Diabetes & Endocrinology
|11th Mar, 2026
|The Lancet
Diabetes & Endocrinology
|11th Mar, 2026
|The Lancet
Diabetes & Endocrinology
|11th Mar, 2026
|The Lancet
Diabetes & Endocrinology
|11th Mar, 2026
|The Lancet
Diabetes & Endocrinology
|11th Mar, 2026
|The Lancet
Diabetes & Endocrinology
|11th Mar, 2026
|The Lancet